Status:
COMPLETED
Translation and Validation of Rivermead Mobility Index in Urdu
Lead Sponsor:
Riphah International University
Conditions:
Stroke Patients
Eligibility:
All Genders
45-70 years
Brief Summary
Rivermead Mobility Index (RMI) is an internationally used tool to assess mobility for both research and clinical practice in stroke survivors. This tool had previously been translated into many langua...
Detailed Description
Stroke is the second most common cause of death and the third most common cause of disability in adults worldwide including in Asia. Stroke survivors experience varying degrees of sensory-motor impair...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- patients with chronic stroke; ischemic or hemorrhagic,
- Aged between 40 to 80 years who visited the respective rehabilitation center during the study time
- Those who could read and understand Urdu.
- Exclusion Criteria
Exclusion
Key Trial Info
Start Date :
May 30 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06519227
Start Date
May 30 2021
End Date
November 1 2023
Last Update
July 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Binash Afzal
Lahore, Punjab Province, Pakistan, 54000